Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inmune Bio (INMB) Intangibles (2017 - 2025)

Inmune Bio's Intangibles history spans 9 years, with the latest figure at $16.5 million for Q1 2025.

  • For Q1 2025, Intangibles changed 0.0% year-over-year to $16.5 million; the TTM value through Mar 2025 reached $16.5 million, changed 0.0%, while the annual FY2024 figure was $16.5 million, 0.0% changed from the prior year.
  • Intangibles for Q1 2025 was $16.5 million at Inmune Bio, roughly flat from $16.5 million in the prior quarter.
  • Across five years, Intangibles topped out at $16.5 million in Q1 2021 and bottomed at $16.5 million in Q1 2021.
  • The 5-year median for Intangibles is $16.5 million (2021), against an average of $16.5 million.
  • The largest YoY upside for Intangibles was 0.0% in 2021 against a maximum downside of 0.0% in 2021.
  • A 5-year view of Intangibles shows it stood at $16.5 million in 2021, then changed by 0.0% to $16.5 million in 2022, then changed by 0.0% to $16.5 million in 2023, then changed by 0.0% to $16.5 million in 2024, then changed by 0.0% to $16.5 million in 2025.
  • Per Business Quant, the three most recent readings for INMB's Intangibles are $16.5 million (Q1 2025), $16.5 million (Q4 2024), and $16.5 million (Q3 2024).